Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 305, Issue 10, 2013, Pages

  Hunt, James M ^a   Bethea, Brian ^b   Liu, Xiang ^c,d   Gandjeva, Aneta ^a   Mammen, Pradeep P A ^e   Stacher, Elvira ^f,g   Gandjeva, Marina R ^b   Parish, Elisabeth ^a   Perez, Mario ^a   Smith, Lynelle ^a   Graham, Brian B ^a   Kuebler, Wolfgang M ^c,h   Tuder, Rubin M ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Tongji University   (China)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

^g LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^h ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Left heart failure; Pulmonary circulation; Pulmonary hypertension; Pulmonary veins; Vessel remodeling

Indexed keywords

UROKINASE RECEPTOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART DISEASE; HUMAN; HUMAN TISSUE; LEFT VENTRICULAR ASSIST DEVICE; LUNG BIOPSY; LUNG HEMODYNAMICS; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; PULMONARY VEIN; RAT;

LEFT HEART FAILURE; PULMONARY CIRCULATION; PULMONARY HYPERTENSION; PULMONARY VEINS; VESSEL REMODELING;

ADOLESCENT; ADULT; AGED; ANIMALS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL PROLIFERATION; CHILD; ENDOTHELIUM, VASCULAR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEART DISEASES; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; IMMUNOENZYME TECHNIQUES; LASER CAPTURE MICRODISSECTION; LUNG; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY ARTERY; PULMONARY VEINS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; YOUNG ADULT;

EID: 84887600470     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00186.2013     Document Type: Article

References (36)

1. Aparicio S, Sawant S, Lara N, Barnstable CJ, Tombran-Tink J. Expression of angiogenesis factors in human umbilical vein endothelial cells and their regulation by PEDF. Biochem Biophys Res Commun 326: 387-394, 2005.
2. Arnstein C. Zur Kenntnis der quergestreiften Muskulatur in den Lungenvenen. Zentbl Med Wiss 692-694, 1877.
3. Coleman TG. Cardiac output by dye dilution in the conscious rat. J Appl Physiol 37: 452-455, 1974.
4. Crnkovic S, Hrzenjak A, Marsh LM, Olschewski A, Kwapiszewska G. Origin of neomuscularized vessels in mice exposed to chronic hypoxia. Respir Physiol Neurobiol 179: 342-345, 2011.
5. Demello DE, Reid LM. Embryonic and early fetal development of human lung vasculature and its functional implications. Pediatr Dev Pathol 3: 439-449, 2000.
6. Dorfmuller P, Humbert M, Perros F, Sanchez O, Simonneau G, Muller KM, Capron F. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 38: 893-902, 2007.
7. Dorfmuller P, Montani D, Humbert M. Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension. Eur Respir J 35: 6-8, 2010.
8. Dutly AE, Kugathasan L, Trogadis JE, Keshavjee SH, Stewart DJ, Courtman DW. Fluorescent microangiography (FMA): an improved tool to visualize the pulmonary microvasculature. Lab Invest 86: 409-416, 2006.
9. Gao Y, Zhou H, Ibe BO, Raj JU. Prostaglandins E2 and I2 cause greater relaxations in pulmonary veins than in arteries of newborn lambs. J Appl Physiol 81: 2534-2539, 1996.
10. Graham BB, Mentink-Kane MM, El-Haddad H, Purnell S, Zhang L, Zaiman A, Redente EF, Riches DW, Hassoun PM, Bandeira A, Champion HC, Butrous G, Wynn TA, Tuder RM. Schistosomiasis induced experimental pulmonary hypertension: role of interleukin-13 signaling. Am J Pathol 177: 1549-1561, 2010.
11. Guazzi M, Arena R. Pulmonary hypertension with left-sided heart disease. Nat Rev Cardiol 7: 648-659, 2010.
12. Hall SM, Hislop AA, Haworth SG. Origin, differentiation, and maturation of human pulmonary veins. Am J Respir Cell Mol Biol 26: 333-340, 2002.
13. Hentschel T, Yin N, Riad A, Habbazettl H, Weimann J, Koster A, Tschope C, Kuppe H, Kuebler WM. Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure. Anesthesiology 106: 124-131, 2007.
14. Hoffmann J, Yin J, Kukucka M, Yin N, Saarikko I, Sterner-Kock A, Fujii H, Leong-Poi H, Kuppe H, Schermuly RT, Kuebler WM. Mast cells promote lung vascular remodelling in pulmonary hypertension. Eur Respir J 37: 1400-1410, 2011.
15. Huang W, Kingsbury MP, Turner MA, Donnelly JL, Flores NA, Sheridan DJ. Capillary filtration is reduced in lungs adapted to chronic heart failure: morphological and haemodynamic correlates. Cardiovasc Res 49: 207-217, 2001.
16. Jones WK, Sanchez A, Robbins J. Murine pulmonary myocardium: developmental analysis of cardiac gene expression. Dev Dyn 200: 117-128, 1994.
17. Khanna M, Wang F, Jo I, Knabe WE, Wilson SM, Li L, Bum-Erdene K, Li J, Sledge W, Khanna R, Meroueh SO. Targeting multiple conformations leads to small molecule inhibitors of the uPAR. uPA protein-protein interaction that block cancer cell invasion. ACS Chem Biol 6: 1232-1243, 2011.
18. Kim YH, Hu H, Guevara-Gallardo S, Lam MT, Fong SY, Wang RA. Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis. Development 135: 3755-3764, 2008.
19. Kiyan J, Kiyan R, Haller H, Dumler I. Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta. EMBO J 24: 1787-1797, 2005.
20. Klika E, Zajicova A, Votavova B. [Participation of the myocardium in the formation of the pulmonary vein wall of small mammals (a quantitative study)]. Arkh Anat Gistol Embriol 82: 81-83, 1982.
21. Lantuejoul S, Sheppard MN, Corrin B, Burke MM, Nicholson AG. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. Am J Surg Pathol 30: 850-857, 2006.
22. LaRusch GA, Mahdi F, Shariat-Madar Z, Adams G, Sitrin RG, Zhang WM, McCrae KR, Schmaier AH. Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis. Blood 115: 5111-5120, 2010.
23. Levi M, Moons L, Bouche A, Shapiro SD, Collen D, Carmeliet P. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice. Circulation 103: 2014-2020, 2001.
24. Ludatscher RM. Fine structure of the muscular wall of rat pulmonary veins. J Anat 103: 345-357, 1968.
25. Montani D, Kemp K, Dorfmuller P, Sitbon O, Simonneau G, Humbert M. Idiopathic pulmonary arterial hypertension and pulmonary venoocclusive disease: similarities and differences. Semin Respir Crit Care Med 30: 411-420, 2009.
26. Murali S. Pulmonary hypertension in heart failure patients who are referred for cardiac transplantation. Adv Pulm Hypertens 5: 30-35, 2006.
27. Oudiz RJ. Pulmonary hypertension associated with left-sided heart disease. Clin Chest Med 28: 233-241, x, 2007.
28. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, Hubbard WC, Berdyshev EV, Tuder RM. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 11: 491-498, 2005.
29. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54: S43-S54, 2009.
30. Smith HW, Marshall CJ. Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 11: 23-36, 2010.
31. Stacher E, Graham BB, Hunt JM, Gandjeva A, Groshong SD, McLaughlin VV, Jessup M, Grizzle WE, Aldred MA, Cool CD, Tuder RM. Modern age pathology of pulmonary arterial hypertension. Am J Respir Crit Care Med 186: 261-272, 2012.
32. Wagenvoort CA, Wagenvoort N. Normal circulation of the lungs. In: Pathology of Pulmonary Hypertension, edited by Wagenvoort CA, Wagenvoort N. New York: Wiley, 1977, p. 1-8.
33. Wagenvoort CA, Wagenvoort N. Pulmonary venous hypertension. In: Pathology of Pulmonary Hypertension, edited by Wagenvoort CA, Wagenvoort N. New York: Wiley, 1977, p. 177-216.
34. Walch L, Labat C, Gascard JP, de Montpreville V, Brink C, Norel X. Prostanoid receptors involved in the relaxation of human pulmonary vessels. Br J Pharmacol 126: 859-866, 1999.
35. Yin J, Kukucka M, Hoffmann J, Sterner-Kock A, Burhenne J, Haefeli WE, Kuppe H, Kuebler WM. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure. Circ Heart Fail 4: 198-206, 2011.
36. You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ, Tsai SY. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435: 98-104, 2005.